ask="0.7000"
ask_size="100"
average_daily_volume="171898"
bid="0.5603"
bid_size="1900"
book_value="0.7250"
change="-0.0403"
change_from_200_day_moving_average="-0.6227"
change_from_50_day_moving_average="-0.2512"
change_from_52_week_high="-1.3403"
change_From_52_week_low="0.0997"
change_in_percent="-5.7571%"
close="0.6597"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.60M"
eps_estimate_current_year="-0.9300"
eps_estimate_next_quarter="-0.2300"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.7300"
high_52_weeks="2.0000"
last_trade_date="3/14/2017"
last_trade_price="0.6597"
last_trade_size="3650"
last_trade_time="3:56pm"
low="0.6300"
low_52_weeks="0.5600"
market_capitalization="25.50M"
moving_average_200_day="1.2824"
moving_average_50_day="0.9109"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="6.0000"
open="0.7100"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-48.5586%"
percent_change_from_50_day_moving_average="-27.5737%"
percent_change_from_52_week_high="-67.0150%"
percent_change_from_52_week_low="+17.8036%"
previous_close="0.7000"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.9655"
price_per_sales="2.7606"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="0.3800"
stock_exchange="NMS"
symbol="AVIR"
volume="117550"
weeks_range_52="0.5600 - 2.0000"
